Avidity Biosciences
218 hedge funds and large institutions have $3.96B invested in Avidity Biosciences in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 95 increasing their positions, 65 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
7% less funds holding
Funds holding: 235 → 218 (-17)
31% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 45
70% less call options, than puts
Call options by funds: $9.04M | Put options by funds: $30.3M
Holders
218
Holding in Top 10
9
Calls
$9.04M
Puts
$30.3M
Top Buyers
| 1 | +$138M | |
| 2 | +$46.6M | |
| 3 | +$41.2M | |
| 4 |
RI
RTW Investments
New York
|
+$24M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$22.8M |
Top Sellers
| 1 | -$26.4M | |
| 2 | -$25.5M | |
| 3 | -$20.3M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$19.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$17.9M |
